GC Biopharma Corp. (KRX: 006280)
South Korea flag South Korea · Delayed Price · Currency is KRW
159,600
+200 (0.13%)
Oct 11, 2024, 3:30 PM KST

GC Biopharma Revenue

GC Biopharma had revenue of 417.36B KRW in the quarter ending June 30, 2024, a decrease of -3.58%. This brings the company's revenue in the last twelve months to 1.62T, down -2.12% year-over-year. In the year 2023, GC Biopharma had annual revenue of 1.63T, down -4.95%.

Revenue (ttm)
1,618.47B
Revenue Growth
-2.12%
P/S Ratio
1.12
Revenue / Employee
802.81M
Employees
2,016
Market Cap
1,813.55B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231,626.64B-84.67B-4.95%
Dec 31, 20221,711.31B173.49B11.28%
Dec 31, 20211,537.83B33.71B2.24%
Dec 31, 20201,504.12B147.00B10.83%
Dec 31, 20191,357.12B22.24B1.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition